Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SYFOVRE safely and effectively. See full prescribing information for SYFOVRE. SYFOVRE ® (pegcetacoplan injection), for intravitreal use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
- generic_name
- pegcetacoplan
- product_names
- Pegcetacoplan
- ndc
- 73606-020, 73606-020-01, 73606-020-02, 73606-020-11, 73606-020-12
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en